(FHLC) Fidelity MSCI Health Care - Overview
ETF Category: Health | Exchange: NYSE ARCA (USA) | Market Cap: 2.897m USD | Total Return: 13.1% in 12m
TER: 0.08%
Avg Turnover: 11.0M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
The Fidelity MSCI Health Care Index ETF (FHLC) seeks to track the performance of the MSCI USA IMI Health Care 25/50 Index by investing at least 80% of its assets in constituent securities. This index captures the U.S. health care sector across large, mid, and small-cap segments, utilizing a capped weighting strategy to prevent individual holdings from dominating the portfolio. As a non-diversified fund, it maintains concentrated exposure to industries including pharmaceuticals, biotechnology, and healthcare equipment.
The health care sector is characterized by high research and development (R&D) costs and extensive regulatory oversight by the FDA. Business models in this space often rely on patent protections to maintain profit margins before generic competition enters the market. Investors can use ValueRay to further analyze the fundamental metrics of these underlying holdings. The demand for these services is largely driven by demographic shifts, such as an aging global population requiring increased medical intervention.
- Pharmaceutical drug pricing legislation impacts profit margins for major index holdings
- Medicare reimbursement rate changes dictate revenue stability for healthcare provider components
- Research and development breakthroughs in biotechnology drive speculative capital appreciation
- Federal Reserve interest rate policy influences valuations of growth-oriented healthcare stocks
- Regulatory approval cycles for medical devices determine long-term revenue growth trajectories
Over the past week, the price has changed by +0.44%, over one month by -0.74%, over three months by -5.33% and over the past year by +13.12%.
| Analysts Target Price | - | - |